Lentivirus-mediated p21/Waf-1 short hairpin RNA enhances the cytotoxic effects and replicative potential of a bladder cancer-specific oncolytic adenovirus in vitro

被引:1
作者
Shi, Jie [1 ,3 ]
Fu, Shengjun [3 ]
Wang, Li [2 ]
Tao, Yan [3 ]
Rodriguez, Ronald [4 ]
Wang, Zhiping [3 ]
机构
[1] Lanzhou Univ, Sch Life Sci, Inst Cell Biol, Lanzhou, Peoples R China
[2] Lanzhou Univ, Sch Basic Med Sci, Dept Pharmacol, Lanzhou, Peoples R China
[3] Lanzhou Univ, Hosp 2, Key Lab Urol Dis Gansu Prov, Dept Urol,Inst Urol, 82 Cuiyingmen,Linxia Rd, Lanzhou 730030, Gansu, Peoples R China
[4] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA
基金
中国国家自然科学基金;
关键词
apoptosis; bladder cancer; oncolytic adenovirus; p21/Waf-1; viral replication; STEM-CELL ANTIGEN; UROPLAKIN-II PROMOTER; IDENTIFICATION; COMBINATION; XENOGRAFTS; CARCINOMA; APOPTOSIS; RECEPTOR; THERAPY; VARIANT;
D O I
10.1097/CAD.0000000000000433
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our previous work confirmed that the bladder cancer-specific oncolytic adenovirus Ad/PSCAE/UPII/E1A could selectively replicate in bladder cancer cells, thus causing specific tumor cell lysis. The replicative potential is a crucial factor in determining the therapeutic efficacy of oncolytic adenoviruses. However, viral replication is attenuated by the low-activity promoter that we used, thus compromising viral cytotoxicity. In this study, we investigated the effect of the cell cycle-dependent kinase inhibitor p21/Waf-1 on an adenovirus. We used lentivirus-mediated short hairpin RNA to knock down p21/Waf-1 in two bladder cancer cell lines EJ and 5637. The p21/Waf-1 knockdown not only induced stronger cytopathic effects but also augmented apoptosis, which was closely associated with the enhancement of Fas and the subsequent significant activation of caspase-3. A replicative assay showed that p21/Waf-1 knockdown increased the viral particle production. Western blot analysis confirmed that p21/Waf-1 knockdown upregulated the expression of androgen receptor (AR) and two adenovirus replication indicators E1A and hexon. A luciferase activity assay indicated higher transcriptional activity of the uroplakin II (UPII) promoter in the p21/Waf-1 knockdown cells, and one possible mechanism could be that the increased expression of AR induced the UPII promoter through the AR-binding sites of the prostate stem cell antigen enhancer. These findings indicating that p21/Waf-1 knockdown could enhance cell killing and viral replication have significant implications for the development of bladder cancer-specific oncolytic adenovirus therapies. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:88 / 96
页数:9
相关论文
共 26 条
[1]  
Abol-Enein H, 2003, LANCET, V361, P1927
[2]  
Amara N, 2001, CANCER RES, V61, P4660
[3]   Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice [J].
Conrad, Steven J. ;
El-Aswad, Mohamed ;
Kurban, Esaw ;
Jeng, David ;
Tripp, Brian C. ;
Nutting, Charles ;
Eversole, Robert ;
Mackenzie, Charles ;
Essani, Karim .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
[4]   Prostate Cancer-Specific and Potent Antitumor Effect of a DD3-Controlled Oncolytic Virus Harboring the PTEN Gene [J].
Ding, Miao ;
Cao, Xin ;
Xu, Hai-neng ;
Fan, Jun-kai ;
Huang, Hong-ling ;
Yang, Dong-qin ;
Li, Yu-hua ;
Wang, Jian ;
Li, Runsheng ;
Liu, Xin-Yuan .
PLOS ONE, 2012, 7 (04)
[5]  
Ganly I, 2000, CLIN CANCER RES, V6, P798
[6]   Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses [J].
Hoeti, N. ;
Chowdhury, W. H. ;
Mustafa, S. ;
Ribas, J. ;
Castanares, M. ;
Johnson, T. ;
Liu, M. ;
Lupold, S. E. ;
Rodriguez, R. .
CANCER GENE THERAPY, 2010, 17 (08) :585-597
[7]   Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy [J].
Houti, Naseruddin ;
Chowdhury, Wasim ;
Hsieh, Jer-Tsong ;
Sachs, Markus D. ;
Lupold, Shawn E. ;
Rodriguez, Ronald .
MOLECULAR THERAPY, 2006, 14 (06) :768-778
[8]   Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapy [J].
Howe, JA ;
Demers, GW ;
Johnson, DE ;
Neugebauer, SEA ;
Perry, ST ;
Vaillancourt, MT ;
Faha, B .
MOLECULAR THERAPY, 2000, 2 (05) :485-495
[9]   The systemic treatment of advanced and metastatic bladder cancer [J].
Hussain, SA ;
James, ND .
LANCET ONCOLOGY, 2003, 4 (08) :489-497
[10]   Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma:: a potential treatment strategy [J].
Itamochi, Hiroaki ;
Kigawa, Junzo ;
Kanamori, Yasunobu ;
Oishi, Tetsuro ;
Bartholomeusz, Chandra ;
Nahta, Rita ;
Esteva, Francisco J. ;
Sneige, Nour ;
Terakawa, Naoki ;
Ueno, Naoto T. .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (01) :227-235